Medical Facilities Corporation

TSX:DR.TO

Medical - Care Facilities

Healthcare
$17.43 +1.01%

+$0.18 today

Market cap
$282.59M
Beta
0.34
P/E (TTM)
8.7
EPS (TTM)
$1.47
Dividend yield
2.00%
52W Low $13.59High $18.79

Volume 0.04M

Average 0.02M

DR.TO Net Income

Bottom-line profit after all expenses, interest, and taxes.

Medical Facilities CorporationTSX: DR.TO

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income growth accelerates

Q1 FY2026 net income of $7.78M rose 108.6% year over year, ahead of the -65.6% change in trailing-twelve-month net income. Sequentially, it rose 42.9% from the prior quarter.

Context

  • Net income amounted to 8.2% of revenue in FY2025, down 14.0 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 1 analysts of $41.16M (+95.2%) for the fiscal year ending Dec 2026, a step up from the -71.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$7.78M+42.9% QoQ
Last fiscal yearDec 2025
$21.08M-71.3% YoY
LTMMar 2026
$25.98M-65.6% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+108.6%-26.6%-135.2 pp
1 year-71.3%+95.2%+166.5 pp
3-year CAGR—+19.0%—
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the income statement

Latest · FY2025
21.08M USD
Year-over-year change
-71.3%
4-year CAGR
+8.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How DR.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -65.6% is the 7th highest of 9, against a peer median of +16.4%.
  • Net income amounts to 8.5% of revenue for DR.TO, versus a peer median of 20.9%.
DR.TO Competitors
Net Income for DR.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$33.21M CAD+52.5%—20.9%
CRRX.TOCareRx CorporationLTM Mar 2026CA$27.07M CAD+820.5%—7.2%
DR.TOMedical Facilities CorporationLTM Mar 2026$25.98M USD-65.6%—8.5%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-$8.81M USD+39.0%—17.2%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$25.21M CAD-249.3%—9.2%
PRN.TOProfound Medical Corp.LTM Mar 2026-$38.82M USD-20.0%—206.9%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026-$42.19M USD-100.7%——
TSND.TOTerrAscend Corp.LTM Mar 2026-$81.53M USD-6.2%—31.2%
WEED.TOCanopy Growth CorporationLTM Mar 2026-CA$263.55M CAD+55.9%—84.8%
Peer median (excluding DR.TO) —+16.4%—20.9%

Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue398.63M424.55M445.58M331.53M258.62M
Cost of Revenue130.03M143.93M148.9M111.65M160.42M
Gross Profit268.61M280.63M296.68M219.88M98.2M
Gross Margin67.4%66.1%66.6%66.3%38.0%
Research & Development00000
Selling, General & Admin177.58M198.21M151.73M151.12M119.23M
Operating Expenses191.25M245.69M229.57M158.24M50.72M
Depreciation & Amortization26.77M20.76M21.54M19.37M11.94M
EBITDA103.4M51.15M72.43M82.57M59.41M
EBITDA Margin25.9%12.0%16.3%24.9%23.0%
Operating Income77.36M34.94M67.11M61.64M47.47M
Operating Margin19.4%8.2%15.1%18.6%18.4%
Interest Income76K8.54M717K1.87M2.24M
Interest Expense25.74M12.89M16.5M12.09M3.59M
Other Income / Expenses(26.47M)(17.44M)(14.27M)(10.53M)(7.19M)
Income Before Tax50.89M17.5M52.32M51.11M40.28M
Pre-Tax Margin12.8%4.1%11.7%15.4%15.6%
Income Tax Expense4.4M5.21M8.33M(5.69M)5.06M
Net Income15.5M(4.41M)18.5M73.49M21.08M
Net Margin3.9%-1.0%4.2%22.2%8.2%
EPS (Basic)1.500.420.731.031.09
EPS (Diluted)1.490.420.731.031.09
Weighted Avg Shares31.09M29.37M25.35M18.5M19.48M
Weighted Avg Shares (Diluted)31.13M29.37M25.25M24M19.48M

Medical Facilities Corporation

TSX:DR.TO

Intrinsic Alpha fair value

Locked

Current Price

$17.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.